Review





Similar Products

94
Bioss anti p akt antibody
Anti P Akt Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/Cdk6+(4F7)+Monoclonal+Antibody/pm42124069-74-25-28
Average 94 stars, based on 1 article reviews
anti p akt antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
MedChemExpress cdk4 cdk6 inhibitor palbociclib
Cdk4 Cdk6 Inhibitor Palbociclib, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/Palbociclib/pm42855540-475-16-22
Average 96 stars, based on 1 article reviews
cdk4 cdk6 inhibitor palbociclib - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

96
Proteintech anti cdk6
Anti Cdk6, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/CDK1+Antibody/pm42815951-205-17-18
Average 96 stars, based on 1 article reviews
anti cdk6 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anticdk6 antibody
Anticdk6 Antibody, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/%5BKO+Validated%5D+CDK6+Rabbit+pAb/pm42800630-58-1-7
Average 94 stars, based on 1 article reviews
anticdk6 antibody - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

96
Cell Signaling Technology Inc cdk6
Cdk6, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/CDK6+Mouse+mAb/10__1186_slash_s40170___026___00452___3-133-11-13
Average 96 stars, based on 1 article reviews
cdk6 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

97
Santa Cruz Biotechnology cdk6
Cdk6, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/Cdk6+Antibody/10__1016_slash_j__bneo__2026__100285-47-27-38
Average 97 stars, based on 1 article reviews
cdk6 - by Bioz Stars, 2026-10
97/100 stars
  Buy from Supplier

96
Proteintech cdk6
SDF4 influences the cell cycle progression and apoptosis in glioma cells. A , B Representative Annexin V–FITC/PI flow-cytometry plots and quantification showing increased apoptosis after SDF4 knockdown in H4 and SW1783 cells. C , D Cell-cycle analysis showing an increased G0/G1 fraction and reduced S-phase fraction, indicating G0/G1 arrest. E Immunoblotting showed increased Bax and cleaved caspase-3 and decreased Bcl-2 after SDF4 knockdown. F SDF4 knockdown reduced Cyclin D1, CDK4, and <t>CDK6</t> and increased p21 and p27. G KEGG enrichment analysis identified PI3K-AKT signaling as a candidate pathway for validation. H SDF4 knockdown reduced p-PI3K and p-AKT levels, whereas total PI3K and AKT were comparatively unchanged, supporting an association between SDF4 and PI3K-AKT phosphorylation rather than a direct activation mechanism. Flow-cytometry data are presented as mean ± SD from independent experiments and were analyzed using the two-group test specified in Methods. * P < 0.05. Immunoblots are representative of independent experiments. FITC, fluorescein isothiocyanate; PI, propidium iodide; KEGG, Kyoto Encyclopedia of Genes and Genomes; p-PI3K, phosphorylated PI3K; p-AKT, phosphorylated AKT
Cdk6, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/CDK6+Antibody/pmc13628875-170-12-15
Average 96 stars, based on 1 article reviews
cdk6 - by Bioz Stars, 2026-10
96/100 stars
  Buy from Supplier

86
Accelrys compounds toward cdk6
SDF4 influences the cell cycle progression and apoptosis in glioma cells. A , B Representative Annexin V–FITC/PI flow-cytometry plots and quantification showing increased apoptosis after SDF4 knockdown in H4 and SW1783 cells. C , D Cell-cycle analysis showing an increased G0/G1 fraction and reduced S-phase fraction, indicating G0/G1 arrest. E Immunoblotting showed increased Bax and cleaved caspase-3 and decreased Bcl-2 after SDF4 knockdown. F SDF4 knockdown reduced Cyclin D1, CDK4, and <t>CDK6</t> and increased p21 and p27. G KEGG enrichment analysis identified PI3K-AKT signaling as a candidate pathway for validation. H SDF4 knockdown reduced p-PI3K and p-AKT levels, whereas total PI3K and AKT were comparatively unchanged, supporting an association between SDF4 and PI3K-AKT phosphorylation rather than a direct activation mechanism. Flow-cytometry data are presented as mean ± SD from independent experiments and were analyzed using the two-group test specified in Methods. * P < 0.05. Immunoblots are representative of independent experiments. FITC, fluorescein isothiocyanate; PI, propidium iodide; KEGG, Kyoto Encyclopedia of Genes and Genomes; p-PI3K, phosphorylated PI3K; p-AKT, phosphorylated AKT
Compounds Toward Cdk6, supplied by Accelrys, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/cdk6+compounds+toward/pm42075865-266-22-12
Average 86 stars, based on 1 article reviews
compounds toward cdk6 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

94
ABclonal Biotechnology anti cdk6
SDF4 influences the cell cycle progression and apoptosis in glioma cells. A , B Representative Annexin V–FITC/PI flow-cytometry plots and quantification showing increased apoptosis after SDF4 knockdown in H4 and SW1783 cells. C , D Cell-cycle analysis showing an increased G0/G1 fraction and reduced S-phase fraction, indicating G0/G1 arrest. E Immunoblotting showed increased Bax and cleaved caspase-3 and decreased Bcl-2 after SDF4 knockdown. F SDF4 knockdown reduced Cyclin D1, CDK4, and <t>CDK6</t> and increased p21 and p27. G KEGG enrichment analysis identified PI3K-AKT signaling as a candidate pathway for validation. H SDF4 knockdown reduced p-PI3K and p-AKT levels, whereas total PI3K and AKT were comparatively unchanged, supporting an association between SDF4 and PI3K-AKT phosphorylation rather than a direct activation mechanism. Flow-cytometry data are presented as mean ± SD from independent experiments and were analyzed using the two-group test specified in Methods. * P < 0.05. Immunoblots are representative of independent experiments. FITC, fluorescein isothiocyanate; PI, propidium iodide; KEGG, Kyoto Encyclopedia of Genes and Genomes; p-PI3K, phosphorylated PI3K; p-AKT, phosphorylated AKT
Anti Cdk6, supplied by ABclonal Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/%5BKO+Validated%5D+CDK6+Rabbit+pAb/pm42041705-79-19-20
Average 94 stars, based on 1 article reviews
anti cdk6 - by Bioz Stars, 2026-10
94/100 stars
  Buy from Supplier

86
Abbott Laboratories cdk6
SDF4 influences the cell cycle progression and apoptosis in glioma cells. A , B Representative Annexin V–FITC/PI flow-cytometry plots and quantification showing increased apoptosis after SDF4 knockdown in H4 and SW1783 cells. C , D Cell-cycle analysis showing an increased G0/G1 fraction and reduced S-phase fraction, indicating G0/G1 arrest. E Immunoblotting showed increased Bax and cleaved caspase-3 and decreased Bcl-2 after SDF4 knockdown. F SDF4 knockdown reduced Cyclin D1, CDK4, and <t>CDK6</t> and increased p21 and p27. G KEGG enrichment analysis identified PI3K-AKT signaling as a candidate pathway for validation. H SDF4 knockdown reduced p-PI3K and p-AKT levels, whereas total PI3K and AKT were comparatively unchanged, supporting an association between SDF4 and PI3K-AKT phosphorylation rather than a direct activation mechanism. Flow-cytometry data are presented as mean ± SD from independent experiments and were analyzed using the two-group test specified in Methods. * P < 0.05. Immunoblots are representative of independent experiments. FITC, fluorescein isothiocyanate; PI, propidium iodide; KEGG, Kyoto Encyclopedia of Genes and Genomes; p-PI3K, phosphorylated PI3K; p-AKT, phosphorylated AKT
Cdk6, supplied by Abbott Laboratories, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cdk6/anti+cdk6/pm42030882-123-5-15
Average 86 stars, based on 1 article reviews
cdk6 - by Bioz Stars, 2026-10
86/100 stars
  Buy from Supplier

Image Search Results


SDF4 influences the cell cycle progression and apoptosis in glioma cells. A , B Representative Annexin V–FITC/PI flow-cytometry plots and quantification showing increased apoptosis after SDF4 knockdown in H4 and SW1783 cells. C , D Cell-cycle analysis showing an increased G0/G1 fraction and reduced S-phase fraction, indicating G0/G1 arrest. E Immunoblotting showed increased Bax and cleaved caspase-3 and decreased Bcl-2 after SDF4 knockdown. F SDF4 knockdown reduced Cyclin D1, CDK4, and CDK6 and increased p21 and p27. G KEGG enrichment analysis identified PI3K-AKT signaling as a candidate pathway for validation. H SDF4 knockdown reduced p-PI3K and p-AKT levels, whereas total PI3K and AKT were comparatively unchanged, supporting an association between SDF4 and PI3K-AKT phosphorylation rather than a direct activation mechanism. Flow-cytometry data are presented as mean ± SD from independent experiments and were analyzed using the two-group test specified in Methods. * P < 0.05. Immunoblots are representative of independent experiments. FITC, fluorescein isothiocyanate; PI, propidium iodide; KEGG, Kyoto Encyclopedia of Genes and Genomes; p-PI3K, phosphorylated PI3K; p-AKT, phosphorylated AKT

Journal: BMC Cancer

Article Title: Integrative transcriptomic and experimental analyses identifies SDF4 as an astrocyte-expressed regulator of glioma progression through PI3K-AKT signaling

doi: 10.1186/s12885-026-16635-6

Figure Lengend Snippet: SDF4 influences the cell cycle progression and apoptosis in glioma cells. A , B Representative Annexin V–FITC/PI flow-cytometry plots and quantification showing increased apoptosis after SDF4 knockdown in H4 and SW1783 cells. C , D Cell-cycle analysis showing an increased G0/G1 fraction and reduced S-phase fraction, indicating G0/G1 arrest. E Immunoblotting showed increased Bax and cleaved caspase-3 and decreased Bcl-2 after SDF4 knockdown. F SDF4 knockdown reduced Cyclin D1, CDK4, and CDK6 and increased p21 and p27. G KEGG enrichment analysis identified PI3K-AKT signaling as a candidate pathway for validation. H SDF4 knockdown reduced p-PI3K and p-AKT levels, whereas total PI3K and AKT were comparatively unchanged, supporting an association between SDF4 and PI3K-AKT phosphorylation rather than a direct activation mechanism. Flow-cytometry data are presented as mean ± SD from independent experiments and were analyzed using the two-group test specified in Methods. * P < 0.05. Immunoblots are representative of independent experiments. FITC, fluorescein isothiocyanate; PI, propidium iodide; KEGG, Kyoto Encyclopedia of Genes and Genomes; p-PI3K, phosphorylated PI3K; p-AKT, phosphorylated AKT

Article Snippet: The antibodies included Cyclin D1 (dilution 1:3000; Abcam), CDK4 (dilution 1:1000; CST), CDK6 (dilution 1:1000; Proteintech), P21 (dilution 1:1000; CST), P27 (dilution 1:1000; CST), BAX (dilution 1:2000; CST), Bcl-2 (dilution 1:1000; Abcam), Cleaved caspase-3 (dilution 1:500; Affbiotech), SDF4 (dilution 1:500; Santa Cruz Biotechnology), p-PI3K (dilution 1:1000; Affbiotech), PI3K (dilution 1:2000; CST), p-AKT (dilution 1:1000; CST), AKT (dilution 1:2000; CST), and β-actin (dilution 1:10000; Beijing TDY Biotechnology Co.) targeting various proteins of interest.

Techniques: Flow Cytometry, Knockdown, Cell Cycle Assay, Western Blot, Analysis, Biomarker Discovery, Phospho-proteomics, Activation Assay